These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1504443)

  • 1. Pharmacological treatment strategies in age-related cataracts.
    Harding JJ
    Drugs Aging; 1992; 2(4):287-300. PubMed ID: 1504443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.
    Babizhayev MA; Deyev AI; Yermakova VN; Brikman IV; Bours J
    Drugs R D; 2004; 5(3):125-39. PubMed ID: 15139774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen.
    Blakytny R; Harding JJ
    Exp Eye Res; 1992 Apr; 54(4):509-18. PubMed ID: 1623937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the isoflavone genistein against galactose-induced cataracts in rats.
    Huang R; Shi F; Lei T; Song Y; Hughes CL; Liu G
    Exp Biol Med (Maywood); 2007 Jan; 232(1):118-25. PubMed ID: 17202592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What possibilities exist to modify cataract development on the basis of current biochemical knowledge? Where can drugs act?].
    Hockwin O
    Klin Monbl Augenheilkd; 1985 Jun; 186(6):455-61. PubMed ID: 4046454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation.
    Agarwal R; Iezhitsa I; Awaludin NA; Ahmad Fisol NF; Bakar NS; Agarwal P; Abdul Rahman TH; Spasov A; Ozerov A; Mohamed Ahmed Salama MS; Mohd Ismail N
    Exp Eye Res; 2013 May; 110():35-43. PubMed ID: 23428743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can drugs or micronutrients prevent cataract?
    Harding JJ
    Drugs Aging; 2001; 18(7):473-86. PubMed ID: 11482741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.
    Suresha BS; Sattur AP; Srinivasan K
    Can J Physiol Pharmacol; 2012 Apr; 90(4):387-94. PubMed ID: 22423974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary myo-inositol effect on sugar cataractogenesis.
    Beyer-Mears A; Bucci FA; Del Val M; Cruz E
    Pharmacology; 1989; 39(1):59-68. PubMed ID: 2587618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lens in diabetes.
    Bron AJ; Sparrow J; Brown NA; Harding JJ; Blakytny R
    Eye (Lond); 1993; 7 ( Pt 2)():260-75. PubMed ID: 7607346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed progression of diabetic cataractogenesis and retinopathy by Litchi chinensis in STZ-induced diabetic rats.
    Kilari EK; Putta S
    Cutan Ocul Toxicol; 2017 Mar; 36(1):52-59. PubMed ID: 27160797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of curcumin on galactose-induced cataractogenesis in rats.
    Suryanarayana P; Krishnaswamy K; Reddy GB
    Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF; Wyman M; Oates PJ
    Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.
    Abdelkader H; Alany RG; Pierscionek B
    J Pharm Pharmacol; 2015 Apr; 67(4):537-50. PubMed ID: 25643848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
    Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
    J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
    Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.